Global Campaign for Microbicides

Home

Home » GCM in Action » North American Events & Conferences

North American Events & Conferences

In each region, the Global Campaign follows leads of our local partners and endorsers, so that the strategies are appropriate to the context, interest, and capacity of our partner organisations. GCM supported these groups through a combination of site visits, technical assistance, ongoing communications, information resources, skills building workshops and regional strategy meetings.

27 February - 2 March 2011: GCM attends the 18th Conference on Retroviruses and Opportunistic Infections (CROI)

Hynes Convention Center
Boston, MA 

 

11 October 2010: Melissa May spoke at the USAID Development Outreach and Communications Training in Arlington, VA

24 June 2010: What makes a woman vulnerable to HIV?  The other half of the down-low story

PATH
Washington
, DC

GCM hosted presentation on Men who have Sex with Men and Women (MSMW) by Georgetown Professor Lakshmi Goparaju. Dr. Lakshmi Goparaju, assistant professor and project director of the Washington Metropolitan Women’s Interagency HIV Study at Georgetown University, presented “What makes a woman vulnerable to HIV?: The other half of the down-low story” at the PATH offices in Washington, DC. Here presentation talked about women’s perspectives on MSMW behavior.          

High rates of HIV among women from minority communities has been a major public health concern. The District of Columbia is experiencing a generalized and severe HIV epidemic among two of its populations, namely, MSM and female heterosexuals. It is theorized that these two epidemics are intertwined by men who have sex with men and women (MSMW).

 

Increasing attention is being paid to the “bridge” role of MSMW in the potential spread of HIV. While little is known about MSM behavior in this setting, we know almost nothing about women’s perspectives on MSMW. Dr. Goparaju’s research is one of the first studies to generate data on women’s perspectives on MSMW. Further this study contributes to filling some of the gaps in the sexuality discourse on women, MSMW, and gender.

 

Dr. Goparaju has a PhD in cultural anthropology and has been working in domestic and international public health focusing on HIV, sexuality, reproductive health, and gender.

 

The Global Campaign for Microbicides, as part of its ongoing expert seminar series, is organizing a number of brown bags that focus on the question “what makes a woman vulnerable to HIV?” Each themed discussion will address the issue of susceptibility to HIV from a different perspective—biological, violence and rape, as well as behavioral, cultural, and socio-economic factors that put women at risk of HIV.

 

Watch the video of her presentation:

11 June 2010: Gender and HIV

GCM Steering Committee Chair Dazon Dixon Diallo facilitated a prevention workshop on 11 June in Washington DC, part of a NIH Office of Women’s Health and UNAIDS event called “Bringing Gender Home: Implementing Gender Responsive Programming for US Women and Girls.”  She invited GCM Director Yasmin Halima to present on national and international perspectives on HIV biomedical prevention research. (slides) 

 

2-4 June 2010: InterAction Forum 2010 

Walter E. Washington Convention Center
Washington
, DC

Global Campaign for Microbicides distributed information in the exhibition area.

9 March 2010 Commission on the Status of Women

The Global Campaign for Microbicides is co-sponsor of the

Prevention Now!’s Expanding Access to Female and Male Condoms through Advocacy and Programming Event

Tuesday, March 9, 2010
12:00p.m – 1:30p.m.
Church Center for the United Nations, 2nd Floor
777 United Nations Plaza (corner of 44th St. and First Avenue)
New York City

Panelists:

Kimberly Whipkey, Senior Associate for Advocacy and Outreach, Center for Health and Gender Equity (CHANGE) and the Prevention Now! Campaign

Sarah Davies, Vice Chair, United Nations Committee of Youth Organizations (CoNGO) and Communications Assistant, World YWCA

Martha Brady, Senior Associate, Population Council

Edinah Masiyiwa, Executive Director, Women’s Action Group Zimbabwe

Manju Chatani-Gada, Senior Program Manager, AVAC – Global Advocacy for HIV Prevention and Co-Founder, African Microbicides Advocacy Group (AMAG)

About the event: Female and male condoms are the only dual protection methods we have today that prevent HIV, STIs, and unintended pregnancy. While women can initiate male condom use by negotiating with their partners, female condoms give women a prevention option specifically designed for them to initiate.  Despite the importance of condoms, they are not always accessible or well-programmed. Civil society advocacy is instrumental in securing the funding and political will needed to ensure access to female and male condoms, including comprehensive programming. Panelists will provide examples of programming and advocacy for female and male condoms—including efforts that target youth—and will strategize about the future of advocacy for prevention technologies.

This event is free and open to the public, though space is limited.  To RSVP, please contact Kiki Kalkstein at kkalkstein@genderhealth.org.  

Co-sponsors: Center for Health and Gender Equity (CHANGE); Prevention Now!, an initiative of CHANGE; World YWCA; AVAC - Global Advocacy for HIV Prevention; Global Campaign for Microbicides; Support; The Condom Project; Durex Network; Universal Access to Female Condoms Joint Programme; Centre for Population and Development Activities (CEDPA); and Population Council

20-23 April 2010: The HIV Research Catalyst Forum: Treatment, Prevention, Advocacy 

Renaissance Harborplace Hotel
Baltimore, Maryland

Marc-André LeBlanc, Global Campaign for Microbicides, will be discussing ARV-based Prevention

 

Read about more past trainings, events & conferences here.

 

 Yasmin Halima and Samu Dube attended CROI and the many subsidiary meetings organized around the conference schedule including the AVAC/Fenway Community and Research Forum. Yasmin interviewed Dr. Craig Hendrix, Johns Hopkins, to discuss the first head to head pharmacokinetic study of oral versus topical tenofovir gel and Dr. Peter Anton, University of California – Los Angeles (UCLA), on findings from the use of vaginal tenofovir gel when applied rectally.  Yasmin also conducted a panel discussion on highlights from the conference relating to women and HIV prevention with Dr. Carl Dieffenbach, US National Institutes of Health (NIH), Dr. Diana Dickinson, physician from Botswana, and Dr. Samu Dube from GCM. Videos of the interviews and panel discussion available here.